1. Home
  2. SEED vs PHGE Comparison

SEED vs PHGE Comparison

Compare SEED & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEED
  • PHGE
  • Stock Information
  • Founded
  • SEED 1997
  • PHGE 2015
  • Country
  • SEED China
  • PHGE Israel
  • Employees
  • SEED N/A
  • PHGE N/A
  • Industry
  • SEED Farming/Seeds/Milling
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • SEED Consumer Staples
  • PHGE Health Care
  • Exchange
  • SEED Nasdaq
  • PHGE Nasdaq
  • Market Cap
  • SEED 10.7M
  • PHGE 11.0M
  • IPO Year
  • SEED N/A
  • PHGE N/A
  • Fundamental
  • Price
  • SEED $1.05
  • PHGE $0.46
  • Analyst Decision
  • SEED
  • PHGE Strong Buy
  • Analyst Count
  • SEED 0
  • PHGE 1
  • Target Price
  • SEED N/A
  • PHGE $15.00
  • AVG Volume (30 Days)
  • SEED 67.3K
  • PHGE 271.1K
  • Earning Date
  • SEED 06-26-2025
  • PHGE 08-13-2025
  • Dividend Yield
  • SEED N/A
  • PHGE N/A
  • EPS Growth
  • SEED N/A
  • PHGE N/A
  • EPS
  • SEED N/A
  • PHGE N/A
  • Revenue
  • SEED $12,910,081.00
  • PHGE N/A
  • Revenue This Year
  • SEED N/A
  • PHGE N/A
  • Revenue Next Year
  • SEED N/A
  • PHGE N/A
  • P/E Ratio
  • SEED N/A
  • PHGE N/A
  • Revenue Growth
  • SEED 21.51
  • PHGE N/A
  • 52 Week Low
  • SEED $0.98
  • PHGE $0.34
  • 52 Week High
  • SEED $4.99
  • PHGE $3.86
  • Technical
  • Relative Strength Index (RSI)
  • SEED 56.42
  • PHGE 44.42
  • Support Level
  • SEED $0.98
  • PHGE $0.45
  • Resistance Level
  • SEED $1.61
  • PHGE $0.51
  • Average True Range (ATR)
  • SEED 0.11
  • PHGE 0.05
  • MACD
  • SEED 0.03
  • PHGE 0.01
  • Stochastic Oscillator
  • SEED 42.86
  • PHGE 55.56

About SEED Origin Agritech Limited

Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Share on Social Networks: